Spontaneously occurring cardiovascular lesions in commonly used laboratory animals

Eugene Herman1, Sandy Eldridge1

  • 1Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892 USA.

Insights

Distinguishing spontaneous cardiovascular lesions in lab animals from drug-induced effects is crucial for accurate preclinical toxicity testing. This summary aids researchers in identifying natural pathologies, ensuring reliable drug safety assessments.

Area of Science:

  • Cardiovascular Pathology
  • Preclinical Toxicology
  • Veterinary Pathology

Background:

  • Drug development requires assessing cardiovascular safety.
  • Laboratory animals are used for in vivo toxicity studies.
  • Spontaneous cardiovascular lesions in animals can mimic drug-induced toxicity.

Purpose of the Study:

  • To summarize common spontaneous cardiovascular alterations in laboratory animals.
  • To aid in distinguishing natural lesions from drug-induced cardiotoxicity.
  • To provide a reference for preclinical safety evaluations, especially for anticancer agents.

Main Methods:

  • Review of literature on spontaneous cardiovascular lesions in rodents and non-rodents.
  • Focus on myocardial pathology relevant to preclinical drug testing.
  • Morphologic analysis for differentiating spontaneous versus induced changes.

Main Results:

  • Detailed description of frequently observed spontaneous cardiovascular lesions.
  • Emphasis on myocardial lesions that can confound cardiotoxicity assessments.
  • Identification of specific pathologies that require careful interpretation.

Conclusions:

  • Accurate interpretation of drug-induced cardiotoxicity relies on understanding spontaneous lesions.
  • Knowledge of background pathology is essential for reliable preclinical safety studies.
  • This summary serves as a guide for researchers evaluating cardiovascular drug safety.

Related Concept Videos